BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15717583)

  • 1. Quality control and automation in cervical cytology.
    Kumar N; Jain S
    J Indian Med Assoc; 2004 Jul; 102(7):372, 374, 376 pasim. PubMed ID: 15717583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automation of the Papanicolaou smear: a technology assessment perspective.
    Linder J
    Arch Pathol Lab Med; 1997 Mar; 121(3):282-6. PubMed ID: 9111119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of AutoPap system location-guided screening in the evaluation of cervical cytology smears.
    Stevens MW; Milne AJ; Parkinson IH; Nespolon WW; Fazzalari NL; Arora N; Dodd TJ
    Diagn Cytopathol; 2004 Aug; 31(2):94-9. PubMed ID: 15282720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Automation of cytological analysis of cervical smears].
    Cenci M; Giovagnoli MR; Olla SV; Drusco A; Vecchione A
    Minerva Ginecol; 1999; 51(7-8):291-8. PubMed ID: 10536424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
    Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
    Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
    Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
    J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of visual inspection of the cervix using acetic acid in cervical cancer screening: a comparison with cervical cytology.
    Akinola OI; Fabamwo AO; Oshodi YA; Banjo AA; Odusanya O; Gbadegesin A; Tayo A
    J Obstet Gynaecol; 2007 Oct; 27(7):703-5. PubMed ID: 17999297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid-based cytology for cervical cancer screening.
    Bentz JS
    Expert Rev Mol Diagn; 2005 Nov; 5(6):857-71. PubMed ID: 16255628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An operative model: verification of the quality of the screening Pap test ].
    Montanari GR; Arnaud S; Berardengo E; Campione D; Cozzani C; Parisio F; Viberti L; Ghiringhello B
    Pathologica; 2001 Oct; 93(5):609-10. PubMed ID: 11725370
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid prescreening is as effective at reducing screening error as postscreening with the FocalPoint automated screening device.
    Wilgenbusch H; Mueller G; Neal M; Renshaw AA
    Diagn Cytopathol; 2011 Nov; 39(11):818-21. PubMed ID: 20949451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of the cytology laboratory: specimen processing through diagnosis.
    Joste N
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):549-63; viii. PubMed ID: 19061816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved cervical cancer screening in premenopausal women by combination of Pap smear and speculoscopy.
    Twu NF; Chen YJ; Wang PH; Yu BK; Lai CR; Chao KC; Yuan CC; Yen MS
    Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):114-8. PubMed ID: 16797826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal collection technique and devices for a quality pap smear.
    Marchand L; Mundt M; Klein G; Agarwal SC
    WMJ; 2005 Aug; 104(6):51-5. PubMed ID: 16218317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated cytology. A symposium by correspondence. Chapter V. Requirements of preparation and sample collection problems.
    Acta Cytol; 1971; 15(3):216-35. PubMed ID: 4104210
    [No Abstract]   [Full Text] [Related]  

  • 15. Organisation of cervical cytology screening in Croatia: past, present and future.
    Pajtler M; Audy-Jurković S; Kardum-Skelin I; Mahovlić V; Mozetic-Vrdoljak D; Ovanin-Rakić A
    Coll Antropol; 2007 Apr; 31 Suppl 2():47-54. PubMed ID: 17598505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State of the Art Symposium: prescreening and rescreening.
    O'Leary TJ
    Cancer; 2004 Dec; 102(6):331-3. PubMed ID: 15540232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
    Djemli A; Khetani K; Auger M
    Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An abnormal cervicovaginal cytology smear in uterine carcinosarcoma is an adverse prognostic sign: analysis of 25 cases.
    Snyder MJ; Robboy SJ; Vollmer RT; Dodd LG
    Am J Clin Pathol; 2004 Sep; 122(3):434-9. PubMed ID: 15362375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Debris removal in Pap-smear images.
    Malm P; Balakrishnan BN; Sujathan VK; Kumar R; Bengtsson E
    Comput Methods Programs Biomed; 2013 Jul; 111(1):128-38. PubMed ID: 23582663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.